Longevity blood tests: a beginner's guide to biomarker panels
Prepared by: Research Desk. Sources are linked for verification.
Longevity blood tests are one of the fastest-growing corners of the healthy-aging market. For a set price, a service collects a blood sample, runs a panel of lab markers and returns a report, sometimes with a single "biological age" number at the top. These reports can be a useful way to track numbers over time, but they are also easy to over-read.
This guide explains what the tests measure and labels the type of research behind each kind of result. It also gives a neutral checklist for comparing services before ordering one. It reports research and consumer information only, not advice for any individual.
What a longevity blood test is (and isn't)
Interest in these tests grows out of the idea of healthspan, the years lived in good health. Researchers describe a "healthspan gap": on average, people spend roughly nine years at the end of life in poor health, and chronic disease is a major driver of that gap [1]. For a fuller introduction, see our healthspan vs lifespan explained guide.
"Longevity blood test" is a marketing label, not a medical category. In practice, most products are one of two things, or a combination:
A biomarker panel. A bundle of standard laboratory blood tests, often the same markers used in routine checkups, presented in a consumer-friendly report.
An epigenetic or "biological age" test. This uses chemical marks on DNA to estimate how old, or how fast-aging, a person's biology appears compared with the calendar.
What these tests are not:
They are not a diagnosis. A number outside a range is a data point, not a conclusion.
They are not a forecast of how long any one person will live.
They are not a way to slow aging. No product is FDA-approved to slow aging, as our regulation guide explains.
Types of results a consumer biomarker panel reports
Panels vary in size, from around a dozen markers to many dozens. Most draw from the same families of results:
Result family | Typical examples | What one result cannot show on its own |
|---|---|---|
Blood sugar | Fasting glucose, HbA1c | Why a value is high or low, or where it is heading |
Blood fats | Cholesterol fractions, triglycerides | Overall risk, which depends on many other factors |
Inflammation | High-sensitivity CRP | Whether a raised value reflects a passing infection or something longer-lasting |
Organ function | Kidney and liver markers | The cause of any change |
Vitamins and minerals | Vitamin D, ferritin (iron stores) | Whether a change in the number changes anything that matters |
Hormones | Thyroid and sex hormones | How normal day-to-day variation affects a single reading |
Researchers who study the biology of aging describe twelve "hallmarks of aging", including epigenetic alterations, mitochondrial dysfunction, cellular senescence and chronic inflammation [2]. Standard blood markers are at best indirect windows onto processes like these. A panel doesn't measure "aging" directly. It measures chemistry in a blood sample on one day.
Reference ranges vs "optimal" ranges. Labs report a reference range based on a population. Many consumer services add their own "optimal" or "target" zones. These can be reasonable, but they are company-defined. A good report shows both and says where its targets come from.
Biological-age and pace-of-aging scores explained
Epigenetic tests read DNA methylation, small chemical tags on DNA that shift with age. Epigenetic alteration is one of the recognised hallmarks of aging [2]. Algorithms called "epigenetic clocks" turn methylation patterns into a single number.
Older clocks estimate a biological age: for example, a 55-year-old whose methylation profile resembles that of a typical 52-year-old. Newer tools estimate the pace of aging, meaning how fast someone appears to be aging right now.
The best-known pace measure is DunedinPACE [3]:
How it was built. Researchers used the Dunedin Study, which has followed about 1,000 people born in one New Zealand city in 1972–73. They tracked how 19 biomarkers of organ-system health changed across ages 26, 32, 38 and 45, then trained an algorithm to estimate that rate of change from DNA methylation in a single blood sample [3].
How to read it. The score is expressed as years of biological aging per calendar year. A value of 1.0 is average; above 1.0 suggests faster aging and below 1.0 slower [3].
What the research found. In other study groups, faster DunedinPACE was associated with chronic disease, disability and death. The measure also showed high test-retest reliability [3].
Study type. Observational cohort research, with validation in additional cohorts. It shows associations at the group level.
What research can and cannot conclude from one result
What it can support: At the population level, people with a faster measured pace of aging were, on average, more likely to develop chronic disease and disability [3]. Tracking the same markers with the same lab over time can show trends that a single snapshot misses.
What it cannot support:
Individual prediction. A group-level association doesn't say what will happen to one person.
Cause and effect. Observational studies can't show that changing a score changes outcomes. No test score has yet been shown to improve health outcomes just by changing it.
Comparisons between brands. Different clocks use different algorithms and can give different answers for the same person. A commercial "biological age" may not be the measure tested in published research.
Precision from a single draw. Many blood markers shift with recent meals, exercise, sleep, illness or time of day. One unusual value is a reason for a repeat test, not a verdict.
How to compare test services: a buyer's checklist
A well-chosen test gives a clear, repeatable record of numbers over time. A poorly chosen one gives a glossy report built on unclear methods. These neutral criteria separate the two:
Lab accreditation. In the U.S., CLIA certification, ideally with CAP accreditation, is a widely used marker of lab quality. A reputable service names its lab partner.
Markers included. Check the exact marker list, not just the panel name, and note which markers are paid add-ons.
Sample collection. A venous draw at a lab location allows larger panels. At-home finger-prick kits are convenient, but the small sample limits which markers can be run.
Algorithm transparency. For any biological-age or pace score, the service should name its algorithm and say whether it is published in a peer-reviewed journal.
Report clarity. Strong reports show the lab's reference range separately from any company "optimal" zone, explain what a result cannot show, and avoid single-number verdicts.
Retesting and consistency. Trend data is only comparable when the same lab and methods are used each time.
Price transparency. Compare the all-in price, including draw fees, shipping and add-ons, and check whether it is a one-off purchase or an auto-renewing subscription.
Data privacy. Look at how blood and DNA data are stored, whether they are shared or sold, and how they can be deleted. Epigenetic data comes from DNA, so these terms matter.
Claims language. Services that present results as information to track and discuss are a stronger sign than those promising to change aging itself.
Checklist question | Stronger sign | Weaker sign |
|---|---|---|
Who runs the analysis? | Named, accredited lab | No lab named |
Is the age algorithm published? | Peer-reviewed citation given | "Proprietary" with no detail |
How are ranges shown? | Lab range and company target, both labelled | Only colour-coded "scores" |
What does it cost over a year? | Clear all-in price | Hidden fees, auto-renewal |
What happens to the data? | Clear deletion and no-sale terms | Vague sharing language |
Red flags in longevity test marketing
FDA describes health fraud scams as "products that claim to prevent, treat, or cure diseases or other health conditions, but are not proven safe and effective for those uses". It warns that they waste money and can delay proper diagnosis and care [4]. Test marketing can borrow the same tactics. Warning signs include:
Promises to "turn back the clock" or to make someone years younger.
A test bundled with a product sale, where the report recommends the seller's own pills or powders. Dietary supplements do not need FDA approval before they are sold [5].
"Proprietary" age scores with no published method.
Countdown timers and "act now" pricing.
Testimonials in place of evidence, such as "my biological age dropped ten years".
Our guide to longevity product rules and fraud warning signs covers label claims and these red flags in more detail.
Tools and further reading
The checklist above works for any biomarker or at-home lab service. Comparing two or three options side by side on lab accreditation, marker list, report clarity, privacy and full annual price is the quickest way to find a strong fit.
Paid links on this site are always marked next to the link, and partners have no say over what we write. Read more about how affiliate links are labelled.
Common questions
Is a longevity panel different from a routine checkup panel? The individual markers often overlap heavily. The differences are usually the number of markers, the report design, company-defined target ranges and, in some cases, an added epigenetic score.
How often do people retest? Services offer different schedules. Research on pace-of-aging measures tracks change over years, not weeks [3]. Very frequent retesting mainly adds cost and captures normal day-to-day variation.
Can a biological-age score go down? Scores can change between tests for many reasons, including measurement noise and algorithm updates. A lower number has not been shown to change future health outcomes on its own.
Does a "good" result mean nothing else matters? No. In large observational studies, higher cardiorespiratory fitness [6], more daily steps [7] and muscle-strengthening activity [8] were each associated with lower all-cause mortality. These are associations, not proof of cause and effect, and our evidence-ranked guide summarises them.
Last updated: 18 October 2026.
Not medical advice. This page reports published research and regulatory records for information only.
Research-only notice: Content on this site is provided for research and educational purposes only and is not intended for human use. It is not medical advice.
Translation notice: Some content on this site may have been machine-translated using Google Translate and may contain errors.